The FTC's Overreaching Regulation Of Homeopathic Drugs

Law360, New York (December 7, 2016, 3:17 PM EST) -- Todd A. Harrison

Claudia Lewis On Nov. 15, 2016, the U.S. Federal Trade Commission decided once again to force itself into the U.S. Food and Drug Administration’s ill-fitting shoes, this time by effectively establishing safety and effectiveness standards for over-the-counter (OTC) homeopathic drugs. In particular, the FTC issued a new policy statement taking the position that claims for homeopathic drugs, like other health-related claims for other types of products (e.g., dietary supplements or allopathic OTC drugs), must be substantiated by “competent and reliable scientific evidence.” From the FTC’s perspective, reliance on “traditional homeopathic theories” (i.e., the foundation of an entire body...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS